1-4 of 4
Amanda P. Liggins
Close
Sort by
Journal Articles

Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies

Andrew J Campbell, MD, PhD, Kamel Ait-Tahar, PhD, Suketu D. Patel, MSc, Martin Barnardo, FRCPath, Amanda P Liggins, BSc, PhD, Maite Caibes, BSc, Alison Banham, DPhil, Graham Collins, MD, PhD, Chris S.R Hatton, MD, Karen Pulford, PhD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 4294.
https://doi.org/10.1182/blood.V116.21.4294.4294
Published: 2010
Journal Articles

PASD1 is a potential multiple myeloma–associated antigen

Surinder S. Sahota, C. Madusha Goonewardena, Christopher D. O. Cooper, Amanda P. Liggins, Kamal Ait-Tahar, Niklas Zojer, Freda K. Stevenson, Alison H. Banham, Karen Pulford
Journal: Blood
Blood (2006) 108 (12): 3953–3955.
https://doi.org/10.1182/blood-2006-04-014621
Published: 2006
Journal Articles

Identification of Circulating Autoantibodies in Patients with Lymphoma Using Antigen Arrays.

Karen Pulford, PhD, Hong Chen, MD, Kamel Ait-Tahar, PhD, Amanda P. Liggins, PhD, Christopher D.O. Cooper, MSc, Graham Collins, MRCP, Chris S.R. Hatton, MRCPath, Edith Gould, BSc, David Toomey, PhD, Alison H. Banham, DPhil, Derek Murphy, PhD
Journal: Blood
Blood (2006) 108 (11): 2397.
https://doi.org/10.1182/blood.V108.11.2397.2397
Published: 2006
Journal Articles

Protein Expression Profiles Confirm PASD1 as a Cancer Testis Antigen and a Potential Candidate for Lymphoma Immunotherapy.

Christopher D.O. Cooper, MBiochem, MRes, Amanda P. Liggins, PhD, Kamel Ait-Tahar, PhD, Alison H. Banham, DPhil, Karen Pulford, PhD
Journal: Blood
Blood (2005) 106 (11): 2825.
https://doi.org/10.1182/blood.V106.11.2825.2825
Published: 2005